NZ598124A - Compounds for treatment of inflammation - Google Patents
Compounds for treatment of inflammationInfo
- Publication number
- NZ598124A NZ598124A NZ598124A NZ59812410A NZ598124A NZ 598124 A NZ598124 A NZ 598124A NZ 598124 A NZ598124 A NZ 598124A NZ 59812410 A NZ59812410 A NZ 59812410A NZ 598124 A NZ598124 A NZ 598124A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treatment
- inflammation
- compounds
- disclosure relates
- pain
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 208000002193 Pain Diseases 0.000 abstract 2
- FGEWTNKUNGVHKT-UHFFFAOYSA-N 2-[(2-chloro-3,4-dimethoxyphenyl)methylideneamino]guanidine Chemical compound COC1=CC=C(C=NNC(N)=N)C(Cl)=C1OC FGEWTNKUNGVHKT-UHFFFAOYSA-N 0.000 abstract 1
- GMPFJUWWIIZIBM-UHFFFAOYSA-N 2-amino-1-benzylideneguanidine Chemical class NNC(=N)N=CC1=CC=CC=C1 GMPFJUWWIIZIBM-UHFFFAOYSA-N 0.000 abstract 1
- 208000005298 acute pain Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0913427A GB0913427D0 (en) | 2009-07-31 | 2009-07-31 | Compounds for treatment of imflammation |
| GBGB1005495.5A GB201005495D0 (en) | 2010-03-31 | 2010-03-31 | Compounds for treatment of inflammation |
| GBGB1010671.4A GB201010671D0 (en) | 2010-06-24 | 2010-06-24 | Compounds for treatment of inflammation |
| PCT/GB2010/001457 WO2011012868A1 (en) | 2009-07-31 | 2010-07-30 | Compounds for treatment of inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ598124A true NZ598124A (en) | 2014-01-31 |
Family
ID=42799430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ598124A NZ598124A (en) | 2009-07-31 | 2010-07-30 | Compounds for treatment of inflammation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120190751A1 (enExample) |
| EP (1) | EP2470270A1 (enExample) |
| JP (1) | JP2013500957A (enExample) |
| CN (1) | CN102573993A (enExample) |
| AU (1) | AU2010277356A1 (enExample) |
| BR (1) | BR112012002267A2 (enExample) |
| CA (1) | CA2769541A1 (enExample) |
| GB (1) | GB2473095A (enExample) |
| IN (1) | IN2012DN00928A (enExample) |
| MX (1) | MX2012001144A (enExample) |
| NZ (1) | NZ598124A (enExample) |
| RU (1) | RU2012106467A (enExample) |
| WO (1) | WO2011012868A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3109237A1 (en) * | 2015-06-22 | 2016-12-28 | AnaMar AB | Novel 5-ht2 antagonists |
| CN105561313B (zh) * | 2016-01-25 | 2018-12-25 | 北京大学 | 降低5-ht2br含量和抑制其活性的物质在制备治疗和预防动脉粥样硬化产品中的应用 |
| US11208475B1 (en) * | 2018-01-30 | 2021-12-28 | Flagship Pioneering Innovations V, Inc. | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators |
| JP2021529729A (ja) * | 2018-05-09 | 2021-11-04 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Ｉ型ｉｆｎ依存性病態を処置するためのグアナベンズ又はその誘導体の使用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0520032B1 (en) * | 1990-03-16 | 1998-09-16 | Beth Israel Hospital Association | Use of spiperone as an immunosuppressant and anti-inflammatory agent |
| US5696128A (en) * | 1994-07-07 | 1997-12-09 | The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College | Method of regulating immune function |
| EP0711553A1 (en) * | 1994-08-09 | 1996-05-15 | Mario Cagnoni | Use of the Melatonin in the traetment of the articular symptoms of trheumatoid arthritis |
| AU7802700A (en) * | 1999-10-06 | 2001-05-10 | Melacure Therapeutics Ab | Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase |
| GB0019357D0 (en) * | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
| US7060711B2 (en) * | 2001-10-25 | 2006-06-13 | Biofrontera Bioscience Gmbh | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| AU2004276812A1 (en) * | 2003-09-25 | 2005-04-07 | Acadia Pharmaceuticals Inc. | Treating neuropathic pain with neuropeptide FF receptor 2 agonists |
| GB0623381D0 (en) * | 2006-11-23 | 2007-01-03 | Acure Pharma Ab | Use of a compound as VEGF inhibitor |
| GB0701170D0 (en) * | 2007-01-22 | 2007-02-28 | Imp Innovations Ltd | Compositions and uses thereof |
| GB0715048D0 (en) * | 2007-08-02 | 2007-09-12 | Glaxo Group Ltd | Novel compounds |
| WO2010109192A1 (en) * | 2009-03-24 | 2010-09-30 | Anamar Ab | Metabolic profiles |
-
2010
- 2010-07-30 JP JP2012522246A patent/JP2013500957A/ja active Pending
- 2010-07-30 CA CA2769541A patent/CA2769541A1/en not_active Abandoned
- 2010-07-30 EP EP10739974A patent/EP2470270A1/en not_active Withdrawn
- 2010-07-30 MX MX2012001144A patent/MX2012001144A/es unknown
- 2010-07-30 RU RU2012106467/15A patent/RU2012106467A/ru not_active Application Discontinuation
- 2010-07-30 AU AU2010277356A patent/AU2010277356A1/en not_active Abandoned
- 2010-07-30 NZ NZ598124A patent/NZ598124A/en unknown
- 2010-07-30 IN IN928DEN2012 patent/IN2012DN00928A/en unknown
- 2010-07-30 WO PCT/GB2010/001457 patent/WO2011012868A1/en not_active Ceased
- 2010-07-30 GB GB1012926A patent/GB2473095A/en not_active Withdrawn
- 2010-07-30 CN CN2010800325573A patent/CN102573993A/zh active Pending
- 2010-07-30 BR BR112012002267A patent/BR112012002267A2/pt not_active IP Right Cessation
- 2010-07-30 US US13/388,174 patent/US20120190751A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2769541A1 (en) | 2011-02-03 |
| WO2011012868A1 (en) | 2011-02-03 |
| IN2012DN00928A (enExample) | 2015-04-03 |
| RU2012106467A (ru) | 2013-09-10 |
| MX2012001144A (es) | 2012-05-08 |
| GB2473095A (en) | 2011-03-02 |
| CN102573993A (zh) | 2012-07-11 |
| AU2010277356A1 (en) | 2012-03-08 |
| BR112012002267A2 (pt) | 2016-11-08 |
| JP2013500957A (ja) | 2013-01-10 |
| GB201012926D0 (en) | 2010-09-15 |
| EP2470270A1 (en) | 2012-07-04 |
| US20120190751A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201101117A1 (ru) | Ингибиторы дпп-4 для лечения диабета у детей | |
| DK2114419T3 (da) | Natriummetaarsenit til anvendelse i behandling af smerte og inflammation | |
| EA201491617A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| IL220129A (en) | History of benzamide, preparations containing them and their use in the treatment of cancer | |
| PT2254869T (pt) | Novos derivados de 1-benzil-3-hidroximetilindazole e suas utilizações no tratamento de doenças com base na expressão de cx3cr1 e p40 | |
| PL3133396T3 (pl) | Sposób leczenia z zastosowaniem leków wychwytujących amoniak | |
| HRP20191953T8 (hr) | DERIVATI 1-BENZIL-3-HIDROKSIMETILINDAZOLA I NJIHOVA UPORABA U LIJEČENJU BOLESTI KOJE SE BAZIRAJU NA EKSPRESIJI MCP-1, CX3CR1 i P40 | |
| MY143269A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder | |
| BRPI0912687A2 (pt) | uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia | |
| GB201316955D0 (en) | Composition comprising a diindolymethane and a retinoid to treat a skin condition | |
| MX359181B (es) | Hidrolizado de colágeno y uso del mismo. | |
| MY155340A (en) | Use of cathepsin c | |
| IL204668A0 (en) | Use of sulfonyl - substituted 2 - sulfonylaminobenzoic acid n - phenylamides in the treatment of pain | |
| NZ598124A (en) | Compounds for treatment of inflammation | |
| MY157007A (en) | Novel possibility of controlling giardiosis | |
| PL2330892T3 (pl) | Sposoby leczenia z zastosowaniem leków wychwytujących amoniak | |
| EA201000864A1 (ru) | Фенилоксетанильные производные | |
| DK2155179T3 (da) | Axomadol til smertebehandling arthrose | |
| PL2475361T3 (pl) | N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego | |
| MY179784A (en) | Use of cathepsin h | |
| UA44395U (ru) | Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении | |
| BR112012025829A2 (pt) | ''composição de tratamento, composição líquido e utilização'' | |
| UA50825U (ru) | Применение антагониста рецепторов интерлейкина-1 в качестве средства гипоурикемического действия | |
| UA92646C2 (ru) | применение производных 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с актопротекторным действием |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 JUL 2017 BY GRIFFITH HACK Effective date: 20140805 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 30 JUL 2030 BY GRIFFITH HACK Effective date: 20140912 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 JUL 2020 BY GRIFFITH HACK Effective date: 20140912 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 JUL 2023 BY GRIFFITH HACK Effective date: 20140912 |
|
| ASS | Change of ownership |
Owner name: HPF IP HOLDING, LU Effective date: 20160303 |